Giovanni Mettivier

Prof. Giovanni Mettivier

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2015 in Medical Physics
Verified
Journal Article
Closed access
ASAntonio Sarno
Antonio Sarno
GMGiovanni Mettivier
Giovanni Mettivier
PRPaolo Russo
Paolo Russo

1 March 2021 in Physica Medica
Verified
Journal Article
Closed access
MAMichele Avanzo
Michele Avanzo
MPMassimiliano Porzio
Massimiliano Porzio
LLLeda Lorenzon
Leda Lorenzon
LMLisa Milan
Lisa Milan
RSRoberto Sghedoni
Roberto Sghedoni
GMGiovanni Mettivier
Giovanni Mettivier

8 March 2021 in Medical Physics
Verified
Journal Article
Closed access
PDF file
ASAntonio Sarno
Antonio Sarno
GMGiovanni Mettivier
Giovanni Mettivier
FFFrancesca di Franco
Francesca di Franco
AVAntonio Varallo
Antonio Varallo
KBKristina Bliznakova
Kristina Bliznakova
PRPaolo Russo
Paolo Russo

1 May 2016 in Physica Medica
Verified
Journal Article
Closed access
ASA. Sarno
A. Sarno
GMGiovanni Mettivier
Giovanni Mettivier
BGBruno Golosio
Bruno Golosio
POP. Oliva
P. Oliva
GSG. Spandre
G. Spandre
PRPaolo Russo
Paolo Russo

12 August 2015 in Physics in Medicine & Biology
Verified
Journal Article
Closed access
CFC Fedon
C Fedon
FLF Longo
F Longo
GMGiovanni Mettivier
Giovanni Mettivier
RLR Longo
R Longo
Mean glandular dose (MGD) is the main dosimetric quantity in mammography. MGD evaluation is obtained by multiplying the entrance skin air kerma (ESAK) by normalized glandular dose (DgN) coefficients. While ESAK is an empirical quantity, DgN coefficients can only be estimated with Monte Carlo (MC) methods. Thus, a MC parameters benchmark is needed for effectively evaluating DgN coefficients. GEANT4 is a MC toolkit suitable for medical purposes that offers to the users several computational choices. In this work we investigate the GEANT4 performances testing the main PhysicsLists for medical applications. Four electromagnetic PhysicsLists were implemented: the linear attenuation coefficients were calculated for breast glandularity 0%, 50%, 100% in the energetic range 8–50 keV and DgN coefficients were evaluated. The results were compared with published data. Fit equations for the estimation of the G -factor parameter, introduced by the literature for converting the dose delivered in the heterogeneous medium to that in the glandular tissue, are proposed and the application of this parameter interaction-by-interaction or retrospectively is discussed. G4EmLivermorePhysicsList shows the best agreement for the linear attenuation coefficients both with theoretical values and published data. Moreover, excellent correlation factor ( ) is found for the DgN coefficients with the literature. The final goal of this study is to identify, for the first time, a benchmark of parameters that could be useful for future breast dosimetry studies with GEANT4.

28 November 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LBLUCA BROMBAL
LUCA BROMBAL
FAFulvia Arfelli
Fulvia Arfelli
PDPasquale Delogu
Pasquale Delogu
Sandro DonatoSandro Donato
Sandro Donato
GMGiovanni Mettivier
Giovanni Mettivier
CFChristian Fedon
Christian Fedon
In this study we compared the image quality of a synchrotron radiation (SR) breast computed tomography (BCT) system with a clinical BCT in terms of contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), noise power spectrum (NPS), spatial resolution and detail visibility. A breast phantom consisting of several slabs of breast-adipose equivalent material with different embedded targets (i.e., masses, fibers and calcifications) was used. Phantom images were acquired using a dedicated BCT system installed at the Radboud University Medical Center (Nijmegen, The Netherlands) and the SR BCT system at the SYRMEP beamline of Elettra SR facility (Trieste, Italy) based on a photon-counting detector. Images with the SR setup were acquired mimicking the clinical BCT conditions (i.e., energy of 30 keV and radiation dose of 6.5 mGy). Images were reconstructed with an isotropic cubic voxel of 273 µm for the clinical BCT, while for the SR setup two phase-retrieval (PhR) kernels (referred to as “smooth” and “sharp”) were alternatively applied to each projection before tomographic reconstruction, with voxel size of 57 × 57 × 50 µm3. The CNR for the clinical BCT system can be up to 2-times higher than SR system, while the SNR can be 3-times lower than SR system, when the smooth PhR is used. The peak frequency of the NPS for the SR BCT is 2 to 4-times higher (0.9 mm−1 and 1.4 mm−1 with smooth and sharp PhR, respectively) than the clinical BCT (0.4 mm−1). The spatial resolution (MTF10%) was estimated to be 1.3 lp/mm for the clinical BCT, and 5.0 lp/mm and 6.7 lp/mm for the SR BCT with the smooth and sharp PhR, respectively. The smallest fiber visible in the SR BCT has a diameter of 0.15 mm, while for the clinical BCT is 0.41 mm. Calcification clusters with diameter of 0.13 mm are visible in the SR BCT, while the smallest diameter for the clinical BCT is 0.29 mm. As expected, the image quality of the SR BCT outperforms the clinical BCT system, providing images with higher spatial resolution and SNR, and with finer granularity. Nevertheless, this study assesses the image quality gap quantitatively, giving indications on the benefits associated with SR BCT and providing a benchmarking basis for its clinical implementation. In addition, SR-based studies can provide a gold-standard in terms of achievable image quality, constituting an upper-limit to the potential clinical development of a given technique.